HomeCHM • ASX
add
Chimeric Therapeutics Ltd
Previous close
$0.0030
Day range
$0.0030 - $0.0030
Year range
$0.0020 - $0.012
Market cap
3.02M AUD
Avg Volume
6.92M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Times Colonist
1 day ago
S&P/TSX composite down in late-morning trading, U.S. stock markets also lower
0.68%
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 3.57M | 302.99% |
Operating expense | 5.06M | -4.17% |
Net income | -3.79M | 49.43% |
Net profit margin | -106.20 | -124.91% |
Earnings per share | — | — |
EBITDA | -1.64M | 75.63% |
Effective tax rate | 0.36% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.76M | 88.58% |
Total assets | 21.57M | 41.24% |
Total liabilities | 19.60M | 53.06% |
Total equity | 1.97M | — |
Shares outstanding | 3.25B | — |
Price to book | ∞ | — |
Return on assets | -22.18% | — |
Return on capital | -242.26% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -3.79M | 49.43% |
Cash from operations | -2.31M | -61.94% |
Cash from investing | -12.97K | -10.74% |
Cash from financing | 2.73M | 128.63% |
Net change in cash | 344.73K | 245.95% |
Free cash flow | -769.85K | 79.33% |
About
Founded
2020
Website
